www.alldocs.info « cancers »
by www.alldocs.info
the most recent document references on :: cancers
Google
 
 Web   cancers.alldocs.info 
 
    Languages: malattie oncologiche  cancers  cancer  cancer  Krebse          Found 2058 documents         Page 2 of 69   Pages:  <<  <  1  2  3  4  5  6  7  8  9  10  >  >> 
 
 
 
   cancers cancers
     prostate cancer prostate cancer
  cancers.alldocs.infohomepage
www.alldocs.infowww.alldocs.info


 

  Legenda: last week last month

  [31] Radiation Therapy for Prostate Cancer
      PDF [165,5 KB]  From [www.cua.org]  Last viewed: 07.09.2006
Radiation Therapy for Prostate Cancer Prostate cancer often can be cured by radiotherapy. Soon after treatment most men will be able to resume their usual lifestyle. The information in the publication is not intended to convey medical advice or to substitute for direct consultation with a qualified medical practitioner. The Canadian Urological Association, Inc., disclaims all liability and legal responsibility howsoever caused, including negligence, for the information contained in or referenced by this brochure. © 2006. Canadian Urological Association, Inc. All Rights Reserved. of radioactive palladium or iodine are delivered through the needles into the prostate , according to a customized pattern-using sophisticated computer programs - to conform to the shape and size of each man’s prostate . The implantation procedure is much different than the external ...

  [32] Preferences for Different Endocrine Therapies used in Prostate Cancer
      PDF [482,2 KB]  From [www.casodex.net]  Last viewed: 07.09.2006
Preferences for Different Endocrine Therapies used in Prostate Cancer V. Jenkins, T. Edginton, L. Fallowfield Cancer Research UK Psychosocial Oncology Group, BSMS, University of Sussex Funded by an AstraZeneca UK Unrestricted Educational Grant • The aim of this study was to determine the treatment preferences (LHRHa injection or non-steroidal antiandrogen tablets) of 180 healthy men should they hypothetically develop locally advanced prostate cancer . Information included how and where the treatments were administered and the side effect profiles of the drugs. AIM OF STUDY • Current endocrine treatments for patients with locally advanced prostate cancer include: • Leuteinising hormone releasing hormone (LHRH) analogues (e.g. goserelin, leuprorelin) • Non-steroidal antiandrogens (e.g. bicalutamide) • ...

  [33] So You Have Prostate Cancer
      DOC [33,8 KB]  From [www.ricancercouncil.org]  Last viewed: 07.09.2006
  prostate  cancer  1186 SO, YOU HAVE PROSTATE CANCER SO WHAT? Edward G. Thornton, Jr.   This is the beginning of the tale, not the ending. The conclusion of this story has yet to be written, for it is an ongoing epic. I suppose the relevancy of this piece to one's own life is in the eye of the beholder—but then, I think that's true for anything. The information within is to be used however you see fit. I only ask that you share this knowledge free of cost. ~ E.G.T *********************** This all started five years ago in February of '93. A biopsy confirmed I had prostate cancer . After finding out, I questioned God to no end. "Why me?" I would ask. Then I remembered President John F. Kennedy saying, "Why Not?" I soon came to realize exactly "why me." I've been a Civilian Police Dispatcher. I've been a Communications Officer at Brown University. Just the mere fact that I love ...

  [34] NEWS RELEASE First European Consensus Published on the ...
      PDF [94,9 KB]  From [www.uroweb.nl]  Last viewed: 07.09.2006
NEWS RELEASE Embargoed until 1100hrs (Central European Summer Time), Tuesday 11 July 2006 First European Consensus Published on the Chemoprevention of Prostate Cancer This week sees publication by the European Association of Urology (EAU) of the first European consensus recommendations on the role of the selective 5-alpha reductase inhibitor, finasteride in the prevention of prostate cancer 1 . The Consensus addresses the clinical implications of the PCPT ( Prostate Cancer Prevention Trial), published in the New England Journal of Medicine 2 , which reported that finasteride reduced the risk of developing prostate cancer by 25%. Currently, finasteride is one of the principal treatments for men with benign prostatic hyperplasia (BPH). Publication, also in the NEJM , of the MTOPS (Medical Treatment of Prostatic Symptoms) Study 3 ...

  [35] Misconceptions about prostate cancer persist
      PDF [41,4 KB]  From [www.prostatecancerfoundation.org]  Last viewed: 07.09.2006
Home • Search • Art • Stories • Feature Fronts • Columns • Help & Info Stories • Skeds / Advisories • News / Commentary • Sports • Health • Business & Tech • Entertainment • Life / People • Family & Religion • Home & Garden • Scripps Networks • SMWS sports sked for July 12, 2006 • Scripps-McClatchy Western Service News Sked • SCRIPPS HOWARD NEWS SERVICE NEWS BUDGET • SCRIPPS HOWARD NEWS SERVICE BUSINESS BUDGET • SCRIPPS HOWARD NEWS SERVICE LIFESTYLE BUDGET • Scripps-McClatchy Western Service Consolidated Sked • SCRIPPS HOWARD NEWS SERVICE CONSOLIDATED BUDGET view all skeds » Text only version Misconceptions about prostate cancer persist By LEE BOWMAN Scripps Howard News Service 16-JUN-06 ...

  [36] Misconceptions about prostate cancer persist
      PDF [24,0 KB]  From [www.prostatecancerfoundation.org]  Last viewed: 07.09.2006
This story is taken from Health & Science News at sacbee.com. Misconceptions about prostate cancer persist By LEE BOWMAN, Scripps Howard News Service Published 12:44 pm PDT Friday, June 16, 2006 (SH) - Along with all the questionable ties and golfing underwear, health advocates in recent years have used the annual focus on Dad around Father's Day to raise awareness of the ills of man. But the results of a new national survey on public awareness of prostate cancer reveal some cross-gender knowledge gaps. The prostate gland is exclusive to the male reproductive system. Still, the telephone survey of 1,572 adults done for the Prostate Cancer Foundation and the Gillette Prostate Cancer Challenge found that 36 percent of male respondents and 32 percent of female respondents believed that women were also at risk of developing prostate cancer . The survey was released Friday. ...

  [37] Women Can Help Men Talk To Doctors About Prostate Cancer
      PDF [26,6 KB]  From [www.prostatecancerfoundation.org]  Last viewed: 07.09.2006
Content Services Client Login About Contact Jobs Submit News Tip TOP STORIES BUSINESS ENTERTAINMENT HEALTH OFFBEAT POLITICS SPORTS TECHNOLOGY WORLD Women Can Help Men Talk To Doctors About Prostate Cancer June 16, 2006 1:00 p.m. EST Richard Rittierodt - All Headline News Contributor New York, NY (AHN) - According to a survey, the best way to get a man to go talk to his doctor about prostate cancer is for his loved ones to help him by urging him on. Leslie D. Michelson, head of the Prostate Cancer Foundation, says, "Women don't realize how much influence they have with their husbands on matters of health. Daughters, wives and partners may be our secret weapons to get men to talk with their doctors about prostate cancer ." One out of six American men will be affected by prostate cancer . 27,000 men will die from ...

  [38] Prostate Cancer Therapy: Progress and Future Trends
      PDF [313,0 KB]  From [www.touchbriefings.com]  Last viewed: 07.09.2006
Prostate Cancer O N C O L O G Y 2 0 0 6 31 a report by Karol Sikora , MB ChB , PhD , FRCP , FFPM Professor of Cancer Medicine, Imperial College and Scientific Director, Medical Solutions Plc Prostate cancer has many difficulties in its management, over and above those encountered in the management of other types of cancer . This is owing to the variation in the natural history of the disease from patient to patient. Some may appear to suffer from a relatively innocuous form of the disease that doctors might expect to progress slowly and respond well to treatment, but the patient goes on to die within a few months of diagnosis. Other patients appear to suffer from an aggressive form of the disease and they would typically be given a poor prognosis. However, they go on to survive for many years. Typically, patients with localised prostate ...

  [39] KELOWNA PROSTATE CANCER SUPPORT & AWARENESS GROUP NEWSLETTER
      PDF [290,9 KB]  From [www.cpcn.org]  Last viewed: 07.09.2006
1 KELOWNA PROSTATE CANCER SUPPORT & AWARENESS GROUP NEWSLETTER OKANAGAN PROSTATE RESOURCE CENTRE CANADIAN PROSTATE SOCIETY CANCER NETWORK Okanagan Prostate Resource Centre P.O. Box 1253 Suite 210A – 3001 Tutt Street, Lakefield, Ontario, Kelowna, B.C., V1Y 2H4 K0L 2H0 Phone – (250) 712-2002 Phone – (705) 652-9200 Fax – (250) 712-2004 Fax – (705) 652-0663 E-mail – oprc@silk.net 1-866-810-2726 http://www.cpcn.org CCS Cancer Information Line – 1-888-939-3333 Publisher/Editor– Bren Witt Newsletter available on line at – www.cpcn.org VOLUME 9 – ISSUE 12 – (NUMBER 108) – JULY 2006 r. David Kim, a Radiation Oncologist was the guest speaker at the June meeting of the Kelowna Prostate Cancer Support and Awareness Group. Dr Kim spoke on three different subjects ...

  [40] Prostate Cancer Screening: A Decision Guide for African Americans
      PDF [160,5 KB]  From [www.cdc.gov]  Last viewed: 07.09.2006
Screening Prostate Cancer f o r A f r i c a n A m e r i c a n s A D e c i s i o n G u i d e Page 2 This booklet was developed by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC). Published in October 2003. Page 3 1 To help you understand both sides of the issue, let’s begin with the basics. Is screening right for you? The decision is yours. Some medical experts believe all men should be offered regular screening tests for prostate cancer . Other medical experts do not. Page 4 What is the prostate ? The prostate is a walnut-sized gland that only men have. It is part of the reproductive system that makes the fluid that carries sperm. As you can see in the ...

  [41] Prostate Cancer:
      PDF [40,2 KB]  From [www.cdc.gov]  Last viewed: 07.09.2006
Prostate Cancer : The Public Health Perspective 2001 “We must move toward the development of health messages that reflect the best medical knowledge available to date on prostate cancer to meet the information needs of primary care clinicians and of the public.” David Satcher, MD, PhD Surgeon General DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR DISEASE CONTROL AND PREVENTION Safer • Healthier • People A T A G LANCE Page 2 2 The Burden of Prostate Cancer Prostate cancer is the most commonly diagnosed form of cancer , other than skin cancer , among men in the United States and is second only to lung cancer as a cause of cancer -related death among men. The American Cancer Society estimates that 198,100 new cases of prostate cancer ...

  [42] Prostate Cancer: The Public Health Perspective Fact Sheet
      PDF [192,9 KB]  From [www.cdc.gov]  Last viewed: 07.09.2006
Prostate cancer is the most common form of cancer among men in the United States, other than skin cancer . In 2004, approximately 230,110 new cases of prostate cancer will be diag- nosed and 29,900 men will die of the disease, according to the American Cancer Society. Prostate cancer is the second leading cause of cancer deaths of men in the United States, after lung cancer , and the sixth lead- ing cause of death of men overall. FACT SHEET 2004 / 2005 FROM THE DIVISION OF CANCER PREVENTION AND CONTROL 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 Year *Rates are per 100,000 and are age-adjusted to the 2000 U.S. standard population. † Hispanic and non-Hispanic are not mutually exclusive from White, Black, American Indian/ Alaska Native (AI/AN), and Asian or Pacific ...

  [43] FACT SHEET: Prostate Cancer 2003
      PDF [114,1 KB]  From [www.cdc.gov]  Last viewed: 07.09.2006
Prostate cancer is the most common form of cancer , other than skin can- cer, among men in the United States, and it is second only to lung cancer as a cause of cancer -related death among men.The American Cancer Society estimates that in 2003, about 220,900 new cases of prostate cancer will be diagnosed and 28,900 men will die of the disease. FACT SHEET 2003 FROM THE DIVISION OF CANCER PREVENTION AND CONTROL *Rates are age-adjusted to the 2000 U.S. population. † Includes Hispanics of any race. Source: CDC, National Center for Health Statistics. 0 20 40 60 80 100 Deaths per 100,000 Black White 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 Hispanic † American Indian/Alaska Native Asian/Pacific Islander Prostate Cancer Death Rates,* ...

  [44] 2004 Science in Brief Fact Sheet: Prostate Cancer Research and ...
      PDF [177,2 KB]  From [www.cdc.gov]  Last viewed: 07.09.2006
SCIENCE IN BRIEF : Prostate Cancer For more information, please contact: The Centers for Disease Control and Prevention • National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention and Control • Mail Stop K-64, 4770 Buford Highway, NE • Atlanta, GA 30341-3717 • Phone (770) 488-4751 Fax (770) 488-4760 • Voice Information System 1 (888) 842-6355 • E-mail cancerinfo@cdc.gov • Web site http://www.cdc.gov/ cancer Department of Health and Human Services Centers for Disease Control and Prevention 2004/2005 FROM THE DIVISION OF CANCER PREVENTION AND CONTROL Prostate Cancer Research and Evaluation Activities Evaluation of Educational Materials Promoting Informed Decision-Making About Prostate Cancer Screening Clinical guidelines suggest that the potential bene- ...

  [45] Prostate Cancer:
      PDF [157,2 KB]  From [www.cdc.gov]  Last viewed: 07.09.2006
Prostate Cancer : Can We Reduce Mortality and Preserve Quality of Life? AT-A-GLANCE 1997 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES “It is important that we move toward the development of health messages that reflect the best medical knowledge available to date on prostate cancer to meet the information needs of primary care clinicians and of the public.” David Satcher, MD, PhD Director Centers for Disease Control and Prevention Page 2 2 Prostate cancer is the most commonly diagnosed form of nondermatologic cancer among men in the United States and is second only to lung cancer as a cause of cancer - related death.The American Cancer Society (ACS) estimates that 334,500 new cases of prostate cancer will be diagnosed and that approximately 41,800 men will die of the disease ...

  [46] Prostate Cancer:
      PDF [69,1 KB]  From [www.cdc.gov]  Last viewed: 07.09.2006
1 Prostate Cancer : Can We Reduce Mortality While Preserving Quality of Life? AT-A-GLANCE 1994–1995 “Quality of life issues are crucial in the decision making process. The patient’s attitude towards cancer and its treatment, sexual concerns, cost issues, and the extent of family support all play a part.” Diane Blum, MSW, Psychosocial Support for the Man with Prostate Cancer . Primary Care and Cancer (1990) U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service DEP AR TM E N T O F H E A L T H & H U M AN SER VICES • USA CENTERS FOR DISEASE CONTROL AND PREVENTION Page 2 2 0 20 40 60 80 100 120 ...

  [47] Prostate Cancer:
      PDF [82,5 KB]  From [www.cdc.gov]  Last viewed: 07.09.2006
Prostate Cancer : Can We Reduce Deaths and Preserve Quality of Life? AT-A-GLANCE 1998 “It is important that we move toward the development of health messages that reflect the best medical knowledge available to date on prostate cancer to meet the information needs of primary care clinicians and of the public.” David Satcher, MD, PhD Director, Centers for Disease Control and Prevention U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Page 2 2 Prostate cancer is the most commonly diagnosed form of nondermatologic cancer among men in the United States and is second only to lung cancer as a cause of cancer -related death. The American Cancer Society (ACS) estimates that 184,000 new cases of prostate cancer will be diagnosed and that approximately ...

  [48] Prostate Cancer Support Groups in Massachusetts as of 7/5/2006
      PDF [19,6 KB]  From [masspcc.org]  Last viewed: 07.09.2006
Prostate Cancer Support Groups in Massachusetts as of 7/5/2006 Prostate Cancer support groups are open to patients, survivors, relatives, friends, healthcare professionals and others who care. No reservations are necessary and there are no fees. Most groups offer free parking and free refreshments. Meetings are usually monthly and often have professional speakers with audience Q&A and discussion. Learn to cope through knowledge and hope through support. City SupportGroup Address Attleboro First Wed. at Sturdy Memorial Hospital 211 Park Street 7:00PM Karen Messier 508-236-7012 kmessier@studrymemorial.org Boston First Mon. at BIDMC (Women Only) 185 Pilgrim Street 6:00PM Annabelle Bitter 617-499-5665 x345 abitter@mah.harvard.edu Fran Klein 617-625-4875 klein@rcn.com Boston First Mon. at BIDMN ...

  [49] Prostate Cancer Fact Sheet
      PDF [174,4 KB]  From [www.garvan.org.au]  Last viewed: 07.09.2006
What are the facts on Prostate Cancer ? Garvan Institute of Medical Research What is prostate cancer ? The prostate is a walnut- sized gland located immediately beneath the bladder and surrounding the urethra. It is found only in men, with its main function being the production of some of the seminal fluid that nourishes sperm. In normal situations, prostate cells divide under the control of hormones, maintaining the size and functions of the gland. In abnormal situations, this cell division process is uncontrolled, causing a build up of constantly replicating cells. If these cells continue to build up and extend into neighbouring tissues or organs, or move to other parts of the body, then the abnormal condition becomes prostate cancer . Most prostate cancers are very slow- developing and neither the patient nor doctor may ever notice any sign of ...

  [50] sexuality and prostate cancer.qxp
      PDF [198,4 KB]  From [www.prostate-cancer.org.uk]  Last viewed: 07.09.2006
How does prostate cancer affect your sexuality? Many men continue to enjoy sex throughout their lives and well into old age. If you are one of these men you will need to think about how treatment for prostate cancer may affect your sexuality. Treatments can affect your: • ability to get an erection • desire to have sex • ability to ejaculate and orgasm • fertility. What is erectile dysfunction? This is the frequent inability to get or keep an erection strong enough for intercourse or other sexual activity. Erectile dysfunction is also known as ED or impotence. It is a common problem that has several possible causes, including treatment for prostate cancer . For more information on the risks of ED in prostate cancer , read our Treatment fact sheets. Causes of ED Erectile dysfunction can be caused by one or ...

  [51] The role of diet in the prevention of prostate cancer
      PDF [790,8 KB]  From [www.prostate-cancer.org.uk]  Last viewed: 07.09.2006
The role of diet in the prevention of prostate cancer Can diet help prostate cancer ? There is a great deal of circumstantial evidence that suggests that diet is a factor in predisposing men to prostate cancer . However, we cannot really be sure that changing diet later in life can prevent prostate cancer developing. As it might make a difference, there are some easy changes one can make which may reduce the risk. The information that follows reflects some of the current thinking about the benefits of a balanced diet. These benefits include building up resistance to prostate and other cancers. A balanced diet will also help to prevent other problems such as heart disease. Geography and Diet People in Far Eastern countries such as China and Japan are less likely than Westerners to develop cancer . This difference may relate to the genetic ...

  [52] Characterization of Epidemiology Data Relating to Prostate Cancer ...
      PDF [134,9 KB]  From [epa.gov]  Last viewed: 07.09.2006
Characterization of Epidemiology Data Relating to Prostate Cancer and Exposure to Atrazine July 17, 2003 Scientific Advisory Panel Page 2 2 Introduction The FIFRA Scientific Advisory Panel is being asked to review and consider the Agency’s analysis of evidence that exposure to atrazine may be associated with an increased incidence of prostate cancer in humans. The Agency’s analysis considers the currently available epidemiology data and largely focuses on a study at a manufacturing plant in Louisiana. This study , initially funded by Ciba-Geigy, later by Novartis, and now by Syngenta , has been updated a number of times over the years as more data on the mortality and incidence of disease have become available. The study was conducted by Dr. Elizabeth Delzell and her colleagues at the University of Alabama. In addition, the Agency’s analysis considers ...

  [53] Prostate cancer in England_TrendsCover.psd
      PDF [225,9 KB]  From [www.uhce.ox.ac.uk]  Last viewed: 07.09.2006
Page 2 Mortality trends in England; ICD9 (185), ICD10 (C61); File: Sepho 96-04 V2 Prostate cancer in England 1996 to 2004. Mortality trends Authors: Michael Goldacre, Marie Duncan, Paula Cook-Mozaffari, Matthew Davidson, Henry McGuiness, Daniel Meddings Published by: Unit of Health-Care Epidemiology, Oxford University, and South-East England Public Health Observatory, 2006 This document provides a profile of trends in mortality for prostate cancer in England. The period covered is January 1 1996 to December 31 2004. The data are analysed from mortality files supplied to the South East England Public Health Observatories (SEPHO) by the Office for National Statistics (ONS). Mortality rates were calculated for the condition certified as the underlying cause of death and for the disease certified as any mention on the death certificates. Age-specific ...

  [54] A Patient’s Guide to Prostate Cancer
      PDF [1737,7 KB]  From [www.prostatecancercentre.co.uk]  Last viewed: 07.09.2006
A Patient’s Guide to Prostate Cancer Professor Stephen Langley MS FRCS(Urol) Mr John Davies BSc FRCS(Urol) Mr Christopher Eden MS FRCS(Urol) Prostate Cancer Centre,Guildford This booklet is intended to help you understand your prostate and what your operation will involve Page 2 This booklet is written by leading urologists for men and their families who would like to know more about prostate cancer .It is not intended to be a definitive textbook, but aims to provide a basic understanding of the disease, its diagnosis and treatment.Other booklets in this series explore the treatment options described in this general guide in more detail.These more specialist booklets may be given to you by your doctor or they can be viewed and downloaded through the internet at: www.prostatecancercentre.com © 2005 ISBN: 1 898763 13 ...

  [55] A Patient’s Guide to Cryosurgery for Prostate Cancer A Patient’s ...
      PDF [845,9 KB]  From [www.prostatecancercentre.co.uk]  Last viewed: 07.09.2006
A Patient’s Guide to Cryosurgery for Prostate Cancer A Patient’s Guide to Cryosurgery for Prostate Cancer Mr John Davies BSc FRCS(Urol) Mr Christopher Eden MS FRCS(Urol) Professor Stephen Langley MS FRCS(Urol) Prostate Cancer Centre,Guildford This booklet is intended to help you understand your prostate and what your operation will involve Page 2 This is a booklet for men who are either considering treatment, or are being treated,for prostate cancer by cryosurgery.It also provides useful advice and information for their families. It is best read in conjunction with the more general booklet in this series, A Patient’sGuide to Prostate Cancer , which provides an overview of the subject and introduces terms used in this booklet. This booklet may have already been given to you, or it may be ...

  [56] Prostate Cancer
      PDF [186,6 KB]  From [www.cancerboard.ab.ca]  Last viewed: 07.09.2006
Alberta Genito-Urinary Oncology Group Clinical Guidelines: Prostate Cancer April 2005 I. Early Diagnosis and Screening Standard method of detection for prostate cancer The standard methods of detection for prostate cancer are the digital rectal examination (DRE) and measurement of the serum prostate specific antigen (PSA), which should be done in fit men between 50 and 70 years of age where clinically indicated (ADD AMA guidelines re frequency of testing). Although there is good evidence that it increases the detection rate of early stage clinically significant prostate cancers, there is no evidence to date that such early detection leads to reduced mortality; the “gold standard” for early detection tests. Fit men age between the ages of 50 and 75 with at least ten years life expectancy should be made aware of the availability of PSA as a detection test for prostate cancer ...

  [57] 7 NATIONAL PROSTATE CANCER SYMPOSIUM 7 NATIONAL PROSTATE CANCER ...
      PDF [1500,6 KB]  From [www.mh.org.au]  Last viewed: 07.09.2006
Proudly Sponsored by: National Speakers: Dr Helen O’Connell Royal Melbourne Hospital Dr Donald Moss Ballarat Base Hospital Convened by: Department of Urology, The Royal Melbourne Hospital Contact: Professor Tony Costello, Professor and Director of Urology, The Royal Melbourne Hospital, Division of Surgery, University of Melbourne Overview: In 2006 the 7th National Prostate Cancer Symposium will address clinical issues in contemporary cancer management including a live robotic prostectomy (Prof. Thomas Ahlering) video linked live from Epworth Hospital. • new techniques in radical prostatectomy • pelvic neuro anatomy and erectile dysfunction therapy • medical oncology and radiation oncology • new drug strategies in advanced prostate cancer • criteria for active surveillance after prostate cancer diagnosis • nomograms ...

  [58] WHAT WORKS & WHAT DOESN’T WORK WITH PROSTATE CANCER
      PDF [105,9 KB]  From [www.cpcn.org]  Last viewed: 07.09.2006
Tuesday 11 th July 7:30pm Foothills Hospital Auditorium Come and join us at this Prostaid Calgary meeting to hear Dr. Mark Moyad, University of Michigan who will speak on lifestyle changes, dietary supplements and what works and doesn’t work when dealing with prostate cancer . This will be a DVD presentation, originally given by Dr. Moyad at the Canadian Prostate Cancer Network national conference. There is no charge to attend any Prostaid meeting, held on the second Tuesday of every month, at Foothills Hospital Auditorium. No tickets and no reservations required. Light refreshments will be served. Men with prostate cancer , their partners, families and friends are all most welcome to attend. There will be time to ask questions and an opportunity to meet and talk with others on the journey with prostate cancer . Any questions? Call Bob at (403) 253-1911 ...

  [59] Researchers Identify Distinctive Signature for Metastatic Prostate ...
      PDF [150,1 KB]  From [www.hhmi.org]  Last viewed: 07.09.2006
July 24, 2001 For Further Information Contact: Corporate Communications PHONE: 607-547-3914 FAX: 607-547-6994 Leslie Raabe PHONE: 607-547-3037 EMAIL: leslie.raabe@bassett.org Dee Carter PHONE: 607-547-6354 EMAIL: public.relations@bassett.org LARGEST-EVER PROSTATE CANCER PREVENTION STUDY LAUNCHED TODAY Bassett Healthcare currently enrolling men, researchers say COOPERSTOWN, NY - The largest-ever prostate cancer prevention study is being launched today by Bassett Healthcare along with leading healthcare institutions throughout the United States, in cooperation with the National Cancer Institute (NCI) and the Southwest Oncology Group (SWOG). This is one of the first trials ever to address male cancer prevention, and will specifically seek to learn whether selenium and vitamin E, two dietary supplements, can protect against prostate cancer , the most ...

  [60] PROSTATE CANCER
      PDF [16,4 KB]  From [www.va.gov]  Last viewed: 07.09.2006
TRANSMITTAL #: 81 DATE: 04/01/2005 TRICARE CHANGE #: N/A CHAMPVA POLICY MANUAL CHAPTER: 2 SECTION: 3.5 TITLE: PROSTATE CANCER AUTHORITY: Public Law 104-106, Section 701 and 38 CFR 17.272(a) RELATED AUTHORITY: 32 CFR 199.4(e)(3)(ii) and (g)(37) I. EFFECTIVE DATE October 6, 1997 II. PROCEDURE CODE(S) A. CPT codes - 84152, 84153, 84154 B. HCPCS Level II Codes - G0102, G0103, S0605 III. POLICY A. Physical examination. Annual digital rectal examinations are covered and included in the reimbursement of the office visit for men: 1. 40 - to 49 - years of age who have a family history of prostate cancer , and 2. for all men over 50. B. Annual PSA ( P rostate - S pecific A ntigen ) testing is covered for the following categories of males: 1. All men aged 50 - years and older. ...